Citalopram

This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on October 27, 2022.

Return to the list of Patented Medicine Litigation page.

CELEXA – Lundbeck Canada Inc. (NOC Search)

Patents:

1339568: RHOXALPHARMA
2049368: DOMINION, PHARMEL, RATIOPHARM, APOTEC, GENPHARM, RHOXALPHARMA, APOTEX, COBALT
2163840: GENPHARM
2178637: GENPHARM
2291067: GENPHARM
2291072: GENPHARM
2291129: GENPHARM
2291134: GENPHARM
2296468: RHOXALPHARMA
2353693: APOTEC, RATIOPHARM, PHARMASCIENCE, DOMINION, PHARMASCIENCE, DOMINION, PHARMEL, PHARMASCIENCE, COBALT, GENPHARM, RHOXALPHARMA, APOTEX

APOTEC

Other – T-481-04

APOTEX

Appeal – A-174-02 – A-566-03
Infringement – T-575-04 (2009 FC 419, 2011 FC 88)
PM(NOC) – T-135-02 – T-2083-03 – T-2378-03

COBALT

PM(NOC) – T-2050-02 – T-2260-03

DOMINION

PM(NOC) – T-2376-03

GENPHARM

Appeal – A-483-03
PM(NOC) – T-122-02 – T-2082-03

PHARMASCIENCE

PM(NOC) – T-2263-03

PHARMASCIENCE, DOMINION

PM(NOC) – T-13-04

PHARMASCIENCE, DOMINION, PHARMEL

PM(NOC) – T-2412-03

PHARMEL

PM(NOC) – T-2377-03

RATIOPHARM

PM(NOC) – T-1548-03 – T-2150-03

RHOXALPHARMA

PM(NOC) – T-2321-03

Return to the Patented Medicine Litigation page.

Canadian Intellectual Property